Rich Law
@drrichjlaw.bsky.social
Chief Business Officer of Haya Therapeutics! (formerly Exscientia/Recursion CBO), computational chemist by training (Oxford, UCSD, LLNL & Evotec), bike racer, ex-Oxford rower & LFC fan! #YNWA.
It'll be great to see everyone in Bruges and discuss some of the amazing progress that Haya Therapeutics is making in the pipeline and platform for finding, validating & drugging chronic disease state reversing targets in the regulatory genome! #BioEquity🧬 ❤️ 🫁 🦀
May 7, 2025 at 12:16 PM
It'll be great to see everyone in Bruges and discuss some of the amazing progress that Haya Therapeutics is making in the pipeline and platform for finding, validating & drugging chronic disease state reversing targets in the regulatory genome! #BioEquity🧬 ❤️ 🫁 🦀
Congrats to Haya Therapeutics CEO Samir Ounzain on being recognized as a top innovator on the Medicine Makers Power List. Just getting started! @HAYA_lncRNA themedicinemaker.com/awards/the-p...
April 30, 2025 at 9:10 AM
Congrats to Haya Therapeutics CEO Samir Ounzain on being recognized as a top innovator on the Medicine Makers Power List. Just getting started! @HAYA_lncRNA themedicinemaker.com/awards/the-p...
There is massive growth of "crowding" around the same targets in drug R&D over the last 20 years, with huge competition for every pharma/biotech & reduction in cost of entry via Chinese molecules. Novel targets are becoming everything for biotech to compete! $XBI (Aradhana - AZ)
April 30, 2025 at 8:23 AM
There is massive growth of "crowding" around the same targets in drug R&D over the last 20 years, with huge competition for every pharma/biotech & reduction in cost of entry via Chinese molecules. Novel targets are becoming everything for biotech to compete! $XBI (Aradhana - AZ)
Myself, Eric, & Samir, will be at the Swiss Biotech Days May 5-6th (2025), in Basel.
Looking forward to sharing HAYA’s mission to advance disease-modifying medicines faster to patients by harnessing the regulatory genome to reprogram cells & reverse disease.🧬@HAYA_lncRNA
Looking forward to sharing HAYA’s mission to advance disease-modifying medicines faster to patients by harnessing the regulatory genome to reprogram cells & reverse disease.🧬@HAYA_lncRNA
April 17, 2025 at 5:57 PM
Myself, Eric, & Samir, will be at the Swiss Biotech Days May 5-6th (2025), in Basel.
Looking forward to sharing HAYA’s mission to advance disease-modifying medicines faster to patients by harnessing the regulatory genome to reprogram cells & reverse disease.🧬@HAYA_lncRNA
Looking forward to sharing HAYA’s mission to advance disease-modifying medicines faster to patients by harnessing the regulatory genome to reprogram cells & reverse disease.🧬@HAYA_lncRNA
I'll be at the @1STRAND_RNA event in San Diego tomorrow to meet people & listen to what promises to be a fascinating talk from Rudi Micheletti about how Haya Therapeutics @HAYA_lncRNA is unlocking chronic diseases like heart failure & obesity via the regulatory genome.
April 7, 2025 at 8:59 PM
I'll be at the @1STRAND_RNA event in San Diego tomorrow to meet people & listen to what promises to be a fascinating talk from Rudi Micheletti about how Haya Therapeutics @HAYA_lncRNA is unlocking chronic diseases like heart failure & obesity via the regulatory genome.
We're really building something at Haya Therapeutics . . . via @endpts.com - hayatx.com
endpts.com/merck-divers...
endpts.com/merck-divers...
March 15, 2025 at 12:32 PM
We're really building something at Haya Therapeutics . . . via @endpts.com - hayatx.com
endpts.com/merck-divers...
endpts.com/merck-divers...
I’m really thrilled to join up with Samir and the team at HAYA Therapeutics as their new Chief Business Officer!
March 13, 2025 at 12:34 PM
I’m really thrilled to join up with Samir and the team at HAYA Therapeutics as their new Chief Business Officer!
The RNA worldview is changing . . .
March 5, 2025 at 11:30 AM
The RNA worldview is changing . . .
Rallybio reaffirming their commitment to developing life-changing therapies for those affected by rare conditions, on Rare Disease Day. $RLYB $RXRX #RareDiseaseDay2025
February 28, 2025 at 4:00 PM
Rallybio reaffirming their commitment to developing life-changing therapies for those affected by rare conditions, on Rare Disease Day. $RLYB $RXRX #RareDiseaseDay2025
The Recursion $RXRX Pi3k preclinical molecule REC-7735 just revealed - as good, if not better, than the Scorpion molecule STX-478 that received so much attention recently when it was acquired by Lilly for up to $2.5Bn.
February 28, 2025 at 1:43 PM
The Recursion $RXRX Pi3k preclinical molecule REC-7735 just revealed - as good, if not better, than the Scorpion molecule STX-478 that received so much attention recently when it was acquired by Lilly for up to $2.5Bn.
Insitro quietly exits oncology.
February 4, 2025 at 3:05 PM
Insitro quietly exits oncology.
Wait really?? I'll change that now!
January 29, 2025 at 8:42 PM
Wait really?? I'll change that now!
It has been an absolute honour! 🍻
Please stay in touch, & I hope our paths cross again in the future. Feel free to reach out to me at drrichjlaw@gmail.com, here, X, or LinkedIn. 🐟🐟
Wishing you all the best,
Rich.
P.s. this message was partly written by AI. 🤖
Please stay in touch, & I hope our paths cross again in the future. Feel free to reach out to me at drrichjlaw@gmail.com, here, X, or LinkedIn. 🐟🐟
Wishing you all the best,
Rich.
P.s. this message was partly written by AI. 🤖
January 17, 2025 at 6:26 PM
It has been an absolute honour! 🍻
Please stay in touch, & I hope our paths cross again in the future. Feel free to reach out to me at drrichjlaw@gmail.com, here, X, or LinkedIn. 🐟🐟
Wishing you all the best,
Rich.
P.s. this message was partly written by AI. 🤖
Please stay in touch, & I hope our paths cross again in the future. Feel free to reach out to me at drrichjlaw@gmail.com, here, X, or LinkedIn. 🐟🐟
Wishing you all the best,
Rich.
P.s. this message was partly written by AI. 🤖
Car exports by major country over time. Quite a remarkable graph from @edconway.bsky.social basically showing Chinese EVs taking over the world! Most countries now applying huge tariffs on these (apart from the UK!).
December 6, 2024 at 12:08 PM
Car exports by major country over time. Quite a remarkable graph from @edconway.bsky.social basically showing Chinese EVs taking over the world! Most countries now applying huge tariffs on these (apart from the UK!).
On the evening of Mon., Dec. 9 at an @AACR Special Conference in Cancer Research, Recursion's CSO David Hallett will present the first monotherapy data readouts from the ELUCIDATE PH1/2 trial for REC-617, a potential best-in-class CDK7 inhibitor. Tune in on Recursion X, YouTube or LinkedIn channels.
December 5, 2024 at 3:44 PM
On the evening of Mon., Dec. 9 at an @AACR Special Conference in Cancer Research, Recursion's CSO David Hallett will present the first monotherapy data readouts from the ELUCIDATE PH1/2 trial for REC-617, a potential best-in-class CDK7 inhibitor. Tune in on Recursion X, YouTube or LinkedIn channels.
The day is finally here! Exscientia's business combination with
Recursion is officially closed and one TechBio powerhouse has emerged. $RXRX 🚀
ir.recursion.com/news-release...
Recursion is officially closed and one TechBio powerhouse has emerged. $RXRX 🚀
ir.recursion.com/news-release...
November 20, 2024 at 12:19 PM
The day is finally here! Exscientia's business combination with
Recursion is officially closed and one TechBio powerhouse has emerged. $RXRX 🚀
ir.recursion.com/news-release...
Recursion is officially closed and one TechBio powerhouse has emerged. $RXRX 🚀
ir.recursion.com/news-release...
LFG $RXRX 🚀
Join us later today via the Recursion channel on LinkedIn or YouTube.
Join us later today via the Recursion channel on LinkedIn or YouTube.
November 20, 2024 at 9:43 AM
LFG $RXRX 🚀
Join us later today via the Recursion channel on LinkedIn or YouTube.
Join us later today via the Recursion channel on LinkedIn or YouTube.
$EXAI ----> $RXRX. 🥹
November 19, 2024 at 4:30 PM
$EXAI ----> $RXRX. 🥹
Jefferies in London is increasingly similar to JPM in SF, complete with the miserable weather!
November 19, 2024 at 1:15 PM
Jefferies in London is increasingly similar to JPM in SF, complete with the miserable weather!
Was a fascinating discussion of deal making in biotech & pharma.
November 18, 2024 at 2:13 PM
Was a fascinating discussion of deal making in biotech & pharma.
ATB Therapeutics raises €54 Million Series A Financing to Propel Innovative Antibody Payload Technology into Clinical Development.
November 18, 2024 at 9:56 AM
ATB Therapeutics raises €54 Million Series A Financing to Propel Innovative Antibody Payload Technology into Clinical Development.
Looking forward to the ICR Healthcare panel today; part of #Jefferies Healthcare Conference in London. With Shaun Grady (AZ), Elena Cavalli (Astellas), Nathalie ter Wengel (Pfizer), Chris Brown (GSK), & Tay Salimullah (4biocapita/Novartis), hosted by John Wilkinson (Cooley). $EXAI $RXRX #Exscientia
November 18, 2024 at 8:48 AM
Looking forward to the ICR Healthcare panel today; part of #Jefferies Healthcare Conference in London. With Shaun Grady (AZ), Elena Cavalli (Astellas), Nathalie ter Wengel (Pfizer), Chris Brown (GSK), & Tay Salimullah (4biocapita/Novartis), hosted by John Wilkinson (Cooley). $EXAI $RXRX #Exscientia
The sheeple of I&I biotech & pharma. 🐑🐑🐑🐑🐑🐑
November 14, 2024 at 2:04 PM
The sheeple of I&I biotech & pharma. 🐑🐑🐑🐑🐑🐑
Exscientia $EXAI and Recursion $RXRX merger approved by shareholders. 🚀
We'll hold a special call on Wed., Nov. 20, 7:30am ET / 5:30am MT / 12:30pm GMT, to discuss.
Join us on:
▫️LinkedIn: linkedin.com/company/recurs…
Or
▫️YouTube: youtube.com/@RecursionPhar
More: ir.recursion.com/news-releases/
We'll hold a special call on Wed., Nov. 20, 7:30am ET / 5:30am MT / 12:30pm GMT, to discuss.
Join us on:
▫️LinkedIn: linkedin.com/company/recurs…
Or
▫️YouTube: youtube.com/@RecursionPhar
More: ir.recursion.com/news-releases/
November 14, 2024 at 10:38 AM
Exscientia $EXAI and Recursion $RXRX merger approved by shareholders. 🚀
We'll hold a special call on Wed., Nov. 20, 7:30am ET / 5:30am MT / 12:30pm GMT, to discuss.
Join us on:
▫️LinkedIn: linkedin.com/company/recurs…
Or
▫️YouTube: youtube.com/@RecursionPhar
More: ir.recursion.com/news-releases/
We'll hold a special call on Wed., Nov. 20, 7:30am ET / 5:30am MT / 12:30pm GMT, to discuss.
Join us on:
▫️LinkedIn: linkedin.com/company/recurs…
Or
▫️YouTube: youtube.com/@RecursionPhar
More: ir.recursion.com/news-releases/
"Encode & automate the process of drug discovery". $EXAI
automatedsynthesisforum.com
automatedsynthesisforum.com
November 7, 2024 at 3:25 PM
"Encode & automate the process of drug discovery". $EXAI
automatedsynthesisforum.com
automatedsynthesisforum.com